Add to cart
For research use only.
| Synonyms | NARC-1, NARC1, Neural Apoptosis-Regulated Convertase 1, PC9, PCSK9, Proprotein Convertase 9, Proprotein Convertase Subtilisin/Kexin Type 9, Subtilisin/Kexin-Like Protease PC9 |
| Species | Human |
| Expression Host | HEK293 Cells |
| Sequence | Gln31-Gln692(Val474Ile,Gly670Glu) |
| Accession | Q8NBP7 |
| Calculated Molecular Weight | 13.77&58.2 kDa |
| Observed Molecular Weight | 19&60 kDa |
| Tag | C-His |
| Bio-activity | Loaded Biotinylated Human LDL R-Avi-His(PKSH032711) on SA Biosensor, can bind Human APCSK9-His(PKSH032944) with an affinity constant of 0.64 uM as determined in BLI assay. |
| Form | Liquid |
| Purity | > 95 % as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Storage | Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles. |
| Shipping | This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C. |
| Formulation | Supplied as a 0.2 μm filtered solution of 20mM NaH2PO4, 150mM NaCl, 0.1M Arginine, 0.1M Glu, 0.01% Tween20, pH 7.4. |
| Background | Human Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a secretory subtilase belonging to the proteinase K subfamily. PCSK9 is synthesized as a soluble zymogen that undergoes autocatalytic intramolecular processing in the ER ; the pro domain and mature chain secrete together through noncovalent interactions. PCSK9 binds with low-density lipoprotein receptor (LDLR) and plays a major regulatory role in cholesterol homeostasis. Inhibition of PCSK9 function by preventing PCSK9/LDLR interaction is currently being explored as a means of lowering cholesterol levels. PCSK9 also binds to apolipoprotein receptor 2 (ApoER2); and play a role in the neural development. |
Other Clones
1 Results
Other Formats
1 Results
Biotinylated
